{"id":977,"date":"2023-10-27T10:45:12","date_gmt":"2023-10-27T10:45:12","guid":{"rendered":"https:\/\/amm-journal.org\/?p=977"},"modified":"2023-10-27T10:45:12","modified_gmt":"2023-10-27T10:45:12","slug":"structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation","status":"publish","type":"post","link":"https:\/\/amm-journal.org\/index.php\/2023\/10\/27\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\/","title":{"rendered":"Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation"},"content":{"rendered":"<p>Announcing a new publication for <em>Acta Materia Medica<\/em> journal. Mitogen-activated protein kinases (MAPKs) are a group of serine-threonine protein kinases that can be activated by extracellular stimuli. MAPK14 (p38\u03b1) affects major disease processes, while inhibition of p38\u03b1 has been shown to have potential therapeutic effects. Many inhibitors targeting p38\u03b1 have entered clinical trials but have a long development cycle and severe side effects. The authors of this article developed a multi-step receptor structure-based virtual screening method to screen potential bioactive molecules from SPECS and MCDB libraries. Compound\u00a0<strong>10<\/strong>\u00a0was identified as a promising p38\u03b1 inhibitor that may be used in the treatment of p38\u03b1MAPK pathway-related diseases, but corollary studies are warranted.<\/p>\n<p><a href=\"https:\/\/www.scienceopen.com\/hosted-document?doi=10.15212\/AMM-2023-0028\">https:\/\/www.scienceopen.com\/hosted-document?doi=10.15212\/AMM-2023-0028<\/a><\/p>\n<p><em>Acta Materia Medica<\/em> welcomes the submission of research articles, review articles, databases, mini reviews, commentaries, editorials, short communications, case report articles and study protocols.<\/p>\n<p><strong>Submission Process<\/strong><\/p>\n<p>Submissions <em>to Acta Materia Medica<\/em> are made using ScholarOne, the online submission and peer review system. Registration and access are available at <a href=\"https:\/\/mc04.manuscriptcentral.com\/ammed\">https:\/\/mc04.manuscriptcentral.com\/ammed<\/a><\/p>\n<p>Queries about the journal can be sent to editorialoffice@amm-journal.org.<\/p>\n<p>Please visit <a href=\"https:\/\/amm-journal.org\/\">https:\/\/amm-journal.org\/<\/a> to learn more about the journal.<\/p>\n<p><strong>Editorial Board:<\/strong> <a href=\"https:\/\/amm-journal.org\/index.php\/editorial-board\/\">https:\/\/amm-journal.org\/index.php\/editorial-board\/<\/a><\/p>\n<p>There are no author submission or article processing fees.<\/p>\n<p>Follow <strong><em>Acta Materia Medica <\/em><\/strong>on Twitter <a href=\"https:\/\/twitter.com\/AMM_journal\">https:\/\/twitter.com\/AMM_journal<\/a>; <a href=\"https:\/\/www.facebook.com\/Zoonoses-Journal-100462755574114\">Facebook<\/a> (<a href=\"https:\/\/www.facebook.com\/AMMjournal\">https:\/\/www.facebook.com\/AMMjournal<\/a>)<\/p>\n<p><strong>eISSN <\/strong>2737-7946<\/p>\n<p>Qinwen Zheng, Yumeng Zhu and Aoxue Wang et al. Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation.\u00a0<em>Acta Materia Medica.\u00a0<\/em>2023. Vol. 2(3):377-385. DOI: 10.15212\/AMM-2023-0028<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Announcing a new publication for Acta Materia Medica journal. Mitogen-activated protein kinases (MAPKs) are a group of serine-threonine protein kinases that can be activated by extracellular stimuli. MAPK14 (p38\u03b1) affects major disease processes, while inhibition of p38\u03b1 has been shown to have potential therapeutic effects. Many inhibitors targeting p38\u03b1 have entered clinical trials but have [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[234,233],"class_list":["post-977","post","type-post","status-publish","format-standard","hentry","category-news-and-events","tag-mapk-inhibitors","tag-protein-kinases"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation - AMM Journal<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/amm-journal.org\/index.php\/2023\/10\/27\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation - AMM Journal\" \/>\n<meta property=\"og:description\" content=\"Announcing a new publication for Acta Materia Medica journal. Mitogen-activated protein kinases (MAPKs) are a group of serine-threonine protein kinases that can be activated by extracellular stimuli. MAPK14 (p38\u03b1) affects major disease processes, while inhibition of p38\u03b1 has been shown to have potential therapeutic effects. Many inhibitors targeting p38\u03b1 have entered clinical trials but have [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/amm-journal.org\/index.php\/2023\/10\/27\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\/\" \/>\n<meta property=\"og:site_name\" content=\"AMM Journal\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-27T10:45:12+00:00\" \/>\n<meta name=\"author\" content=\"Compuscript\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Compuscript\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2023\\\/10\\\/27\\\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2023\\\/10\\\/27\\\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\\\/\"},\"author\":{\"name\":\"Compuscript\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/0935dba5c919585e39f756ce09930a67\"},\"headline\":\"Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation\",\"datePublished\":\"2023-10-27T10:45:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2023\\\/10\\\/27\\\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\\\/\"},\"wordCount\":271,\"commentCount\":0,\"keywords\":[\"MAPK inhibitors\",\"protein kinases\"],\"articleSection\":[\"News and Events\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2023\\\/10\\\/27\\\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2023\\\/10\\\/27\\\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\\\/\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2023\\\/10\\\/27\\\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\\\/\",\"name\":\"Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation - AMM Journal\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#website\"},\"datePublished\":\"2023-10-27T10:45:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/0935dba5c919585e39f756ce09930a67\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2023\\\/10\\\/27\\\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2023\\\/10\\\/27\\\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2023\\\/10\\\/27\\\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/amm-journal.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#website\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/\",\"name\":\"AMM Journal\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/amm-journal.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/0935dba5c919585e39f756ce09930a67\",\"name\":\"Compuscript\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g\",\"caption\":\"Compuscript\"},\"sameAs\":[\"https:\\\/\\\/amm-journal.org\"],\"url\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/author\\\/ammjadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation - AMM Journal","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/amm-journal.org\/index.php\/2023\/10\/27\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\/","og_locale":"en_GB","og_type":"article","og_title":"Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation - AMM Journal","og_description":"Announcing a new publication for Acta Materia Medica journal. Mitogen-activated protein kinases (MAPKs) are a group of serine-threonine protein kinases that can be activated by extracellular stimuli. MAPK14 (p38\u03b1) affects major disease processes, while inhibition of p38\u03b1 has been shown to have potential therapeutic effects. Many inhibitors targeting p38\u03b1 have entered clinical trials but have [&hellip;]","og_url":"https:\/\/amm-journal.org\/index.php\/2023\/10\/27\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\/","og_site_name":"AMM Journal","article_published_time":"2023-10-27T10:45:12+00:00","author":"Compuscript","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Compuscript","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/amm-journal.org\/index.php\/2023\/10\/27\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\/#article","isPartOf":{"@id":"https:\/\/amm-journal.org\/index.php\/2023\/10\/27\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\/"},"author":{"name":"Compuscript","@id":"https:\/\/amm-journal.org\/#\/schema\/person\/0935dba5c919585e39f756ce09930a67"},"headline":"Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation","datePublished":"2023-10-27T10:45:12+00:00","mainEntityOfPage":{"@id":"https:\/\/amm-journal.org\/index.php\/2023\/10\/27\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\/"},"wordCount":271,"commentCount":0,"keywords":["MAPK inhibitors","protein kinases"],"articleSection":["News and Events"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/amm-journal.org\/index.php\/2023\/10\/27\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/amm-journal.org\/index.php\/2023\/10\/27\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\/","url":"https:\/\/amm-journal.org\/index.php\/2023\/10\/27\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\/","name":"Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation - AMM Journal","isPartOf":{"@id":"https:\/\/amm-journal.org\/#website"},"datePublished":"2023-10-27T10:45:12+00:00","author":{"@id":"https:\/\/amm-journal.org\/#\/schema\/person\/0935dba5c919585e39f756ce09930a67"},"breadcrumb":{"@id":"https:\/\/amm-journal.org\/index.php\/2023\/10\/27\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/amm-journal.org\/index.php\/2023\/10\/27\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/amm-journal.org\/index.php\/2023\/10\/27\/structure-based-virtual-screening-for-novel-p38-mapk-inhibitors-and-a-biological-evaluation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/amm-journal.org\/"},{"@type":"ListItem","position":2,"name":"Structure-based virtual screening for novel p38 MAPK inhibitors and a biological evaluation"}]},{"@type":"WebSite","@id":"https:\/\/amm-journal.org\/#website","url":"https:\/\/amm-journal.org\/","name":"AMM Journal","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/amm-journal.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/amm-journal.org\/#\/schema\/person\/0935dba5c919585e39f756ce09930a67","name":"Compuscript","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g","caption":"Compuscript"},"sameAs":["https:\/\/amm-journal.org"],"url":"https:\/\/amm-journal.org\/index.php\/author\/ammjadmin\/"}]}},"_links":{"self":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/977","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/comments?post=977"}],"version-history":[{"count":1,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/977\/revisions"}],"predecessor-version":[{"id":978,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/977\/revisions\/978"}],"wp:attachment":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/media?parent=977"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/categories?post=977"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/tags?post=977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}